Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1969 Oct;37(2):380–390.

The effect of bretylium on intracellular cardiac action potentials in relation to its anti-arrhythmic and local anaesthetic activity

J Gy Papp, E M Vaughan Williams
PMCID: PMC1703703  PMID: 5348427

Abstract

1. The initial effect of bretylium tosylate on isolated rabbit atria was to increase conduction velocity, contraction heights, spontaneous frequency and maximum driven frequency, and to reduce electrical threshold. At concentrations of 200 mg/l. or less, these were the only effects, and were consistent with the known sympathomimetic actions of bretylium.

2. At extremely high concentrations, 1,200 and 2,400 mg/l., the initial actions were succeeded by weak quinidine-like effects; reduced conduction velocity, spontaneous and maximum driven frequencies, and rate of rise of action potential. The electrical threshold was raised, but contraction heights were not reduced.

3. The local anaesthetic activity of bretylium, measured by reductions in the frog nerve action potential, was 1/90 that of procaine and 1/300 that of propranolol, on a molar basis.

4. Acute pretreatment with bretylium, 20 mg/kg intravenously, significantly increased the amount of infused ouabain required before the appearance of the first signs of atrial arrhythmia in anaesthetized guinea-pigs, but did not prevent ventricular arrhythmias.

5. Pretreatment with bretylium 30 mg/kg subcutaneously 24 hr, and again 4 hr before ouabain infusion, increased the dose of ouabain inducing atrial irregularity and slightly but significantly reduced the incidence of ventricular fibrillation.

Full text

PDF
380

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOURA A. L., GREEN A. F. The actions of bretylium: adrenergic neurone blocking and other effects. Br J Pharmacol Chemother. 1959 Dec;14:536–548. doi: 10.1111/j.1476-5381.1959.tb00961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bacaner M. B. Quantitiative comparison of bretylium with other antifibrillatory drugs. Am J Cardiol. 1968 Apr;21(4):504–512. doi: 10.1016/0002-9149(68)90282-8. [DOI] [PubMed] [Google Scholar]
  3. Bacaner M. B. Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. Am J Cardiol. 1968 Apr;21(4):530–543. doi: 10.1016/0002-9149(68)90286-5. [DOI] [PubMed] [Google Scholar]
  4. Benfey B. G., Varma D. R. Antisympathomimetic and antifibrillatory effects of pronethalol and propranolol. Br J Pharmacol Chemother. 1966 Jan;26(1):3–8. doi: 10.1111/j.1476-5381.1966.tb01804.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boger D. C., Leveque P. E. The anti-arrhythmic effect of (minus) N-(1-phenylethyl) guanidine. Arch Int Pharmacodyn Ther. 1968 Sep;175(1):129–135. [PubMed] [Google Scholar]
  6. Boyajy L. D., Nash C. B. Alteration of ouabain taxicity by cardiac denervation. Toxicol Appl Pharmacol. 1966 Sep;9(2):199–208. doi: 10.1016/0041-008x(66)90114-1. [DOI] [PubMed] [Google Scholar]
  7. Brick I., Hutchison K. J., McDevitt D. G., Roddie I. C., Shanks R. G. Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol. 1968 Sep;34(1):127–140. doi: 10.1111/j.1476-5381.1968.tb07956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. COOPER C. J., FEWINGS J. D., HODGE R. L., WHELAN R. F. EFFECTS OF BRETYLIUM AND GUANETHIDINE ON HUMAN HAND AND FOREARM VESSELS AND ON THEIR SENSITIVITY TO NORADRENALINE. Br J Pharmacol Chemother. 1963 Aug;21:165–173. doi: 10.1111/j.1476-5381.1963.tb01512.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dohadwalla A. N., Freedberg A. S., Vaughan Williams E. M. The relevance of beta-receptor blockade to ouabain-induced cardiac arrhythmias. Br J Pharmacol. 1969 Jun;36(2):257–267. doi: 10.1111/j.1476-5381.1969.tb09503.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ERLIJ D., MENDEZ R. THE MODIFICATION OF DIGITALIS INTOXICATION BY EXCLUDING ADRENERGIC INFLUENCES ON THE HEART. J Pharmacol Exp Ther. 1964 Apr;144:97–103. [PubMed] [Google Scholar]
  11. GILL E. W., WILLIAMS E. M. LOCAL ANAESTHETIC ACTIVITY OF THE BETA-RECEPTOR ANTAGONIST, PRONETHALOL. Nature. 1964 Jan 11;201:199–199. doi: 10.1038/201199a0. [DOI] [PubMed] [Google Scholar]
  12. GILMORE J. P., SIEGEL J. H. Mechanism of the myocardial effects of bretylium. Circ Res. 1962 Mar;10:347–353. doi: 10.1161/01.res.10.3.347. [DOI] [PubMed] [Google Scholar]
  13. HERTTING G., AXELROD J., PATRICK R. W. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br J Pharmacol Chemother. 1962 Feb;18:161–166. doi: 10.1111/j.1476-5381.1962.tb01159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hashimoto K., Chiba S., Tanaka S., Hirata M., Suzuki Y. Adrenergic mechanism participating in induction of atrial fibrillation by ACh. Am J Physiol. 1968 Nov;215(5):1183–1191. doi: 10.1152/ajplegacy.1968.215.5.1183. [DOI] [PubMed] [Google Scholar]
  15. LEVEQUE P. E. GUANETHIDINE AS AN ANTI-FIBRILLATORY AGENT. Nature. 1964 Sep 26;203:1389–1389. doi: 10.1038/2031389a0. [DOI] [PubMed] [Google Scholar]
  16. LUCCHESI B. R. THE EFFECTS OF PRONETHALOL AND ITS DEXTRO ISOMER UPON EXPERIMENTAL CARDIAC ARRHYTHMIAS. J Pharmacol Exp Ther. 1965 Apr;148:94–99. [PubMed] [Google Scholar]
  17. Leveque P. E. Anti-arrhythmic action of bretylium. Nature. 1965 Jul 10;207(993):203–204. doi: 10.1038/207203a0. [DOI] [PubMed] [Google Scholar]
  18. Levy J. V. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties. Eur J Pharmacol. 1968 Feb;2(4):250–257. doi: 10.1016/0014-2999(68)90074-5. [DOI] [PubMed] [Google Scholar]
  19. MORALES AGUILERA A., VAUGHANWILLIAMS E. M. THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS. Br J Pharmacol Chemother. 1965 Apr;24:332–338. doi: 10.1111/j.1476-5381.1965.tb01719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nayler W. G., Chan J., Lowe T. E. Beta adrenergic antagonists, including ICI 50172, and the control of cardiac arrhythmias. Med J Aust. 1968 Jun 29;1(26):1128–1130. doi: 10.5694/j.1326-5377.1968.tb29208.x. [DOI] [PubMed] [Google Scholar]
  21. Papp G., Szekeres L. Influence of stretch and dynamic functional state of the myocardium on tendency of the heart to arrhythmia. Acta Physiol Acad Sci Hung. 1967;32(1):163–174. [PubMed] [Google Scholar]
  22. Raines A., Moros D., Levitt B. The effect of guanethidine on ouabain-induced ventricular arrhythmia in the cat. Arch Int Pharmacodyn Ther. 1968 Aug;174(2):373–377. [PubMed] [Google Scholar]
  23. Raper C., Wale J. Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmias. Eur J Pharmacol. 1968 Aug;4(1):1–12. doi: 10.1016/0014-2999(68)90002-2. [DOI] [PubMed] [Google Scholar]
  24. VAUGHAN WILLIAMS E. M. The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records. Br J Pharmacol Chemother. 1958 Sep;13(3):276–287. doi: 10.1111/j.1476-5381.1958.tb00903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Williams E. M., Whyte J. M. Chemosensitivity of cardiac muscle. J Physiol. 1967 Mar;189(1):119–137. doi: 10.1113/jphysiol.1967.sp008158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. YELNOSKY J., MORTIMER L. C. A brief study of the sympathomimetic cardiovascular effects of bretylium. Arch Int Pharmacodyn Ther. 1961 Feb 1;130:200–206. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES